US Stock MarketDetailed Quotes

RNA Avidity Biosciences

Watchlist

29.500
+0.780+2.72%

Close May 17 16:00 ET

29.380
-0.120-0.41%

Post 19:10 ET

2.82BMarket Cap-9966P/E (TTM)

Avidity Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-43.73%-70.38M

12.63%-119.06M

142.11%16.5M

-15.12%-36.79M

-40.12%-49.81M

-65.57%-48.97M

-43.72%-136.27M

-49.49%-39.19M

-53.78%-31.96M

-26.34%-35.55M

Net income from continuing operations

-31.42%-68.86M

-21.97%-212.22M

-19.76%-60.44M

-20.09%-52.36M

-2.92%-47.03M

-53.04%-52.39M

-47.44%-174M

-30.96%-50.47M

-48.93%-43.6M

-73.38%-45.69M

Depreciation and amortization

63.94%641K

51.48%2.1M

61.42%615K

52.97%566K

64.29%529K

24.52%391K

117.06%1.39M

83.17%381K

110.23%370K

119.05%322K

Other non cash items

20.35%828K

8.33%2.98M

21.00%824K

6.53%734K

6.09%732K

-0.15%688K

304.86%2.75M

--681K

--689K

--690K

Change In working capital

-128.51%-10.34M

764.99%61.13M

1,756.06%68.9M

109.76%7.41M

-515.44%-10.66M

-64.91%-4.53M

52.21%7.07M

-45.51%3.71M

-5.71%3.53M

141.06%2.57M

-Change in prepaid assets

-269.55%-2.53M

47.94%-3.44M

10.82%-3.01M

274.09%5.21M

-489.99%-7.13M

171.68%1.49M

-163.59%-6.62M

-207.32%-3.37M

-137.38%-2.99M

146.86%1.83M

-Change in payables and accrued expense

1.47%-3.96M

-76.11%4.91M

-43.20%5.53M

-42.79%4.87M

-170.30%-1.46M

-1,659.30%-4.02M

73.82%20.57M

96.13%9.73M

38.53%8.51M

265.28%2.07M

-Change in other current liabilities

-14.60%-887K

-88.88%-3.33M

-20.53%-916K

-8.92%-818K

-226.69%-820K

---774K

-652.99%-1.76M

---760K

---751K

---251K

-Change in other working capital

-142.90%-2.96M

1,330.21%62.99M

3,671.92%67.3M

-49.76%-1.84M

-15.04%-1.25M

-32.21%-1.22M

-15.21%-5.12M

-77.90%-1.88M

-8.66%-1.23M

0.64%-1.08M

Cash from discontinued investing activities

Operating cash flow

-43.73%-70.38M

12.63%-119.06M

142.11%16.5M

-15.12%-36.79M

-40.12%-49.81M

-65.57%-48.97M

-43.72%-136.27M

-49.49%-39.19M

-53.78%-31.96M

-26.34%-35.55M

Investing cash flow

Cash flow from continuing investing activities

83.27%-32.75M

31.53%-130.07M

757.05%51.04M

-387.95%-31.48M

360.99%46.05M

-11.51%-195.68M

-130.20%-189.96M

90.76%-7.77M

1,466.50%10.93M

-714.35%-17.64M

Net PPE purchase and sale

49.73%-915K

-49.77%-4.23M

-1.53%-863K

-962.62%-923K

52.95%-622K

-140.11%-1.82M

24.52%-2.82M

50.21%-850K

113.38%107K

-86.72%-1.32M

Net investment purchase and sale

83.58%-31.83M

32.75%-125.84M

850.26%51.9M

-382.27%-30.56M

385.94%46.67M

-10.96%-193.86M

-137.55%-187.13M

91.60%-6.92M

--10.83M

-555.92%-16.32M

Cash from discontinued investing activities

Investing cash flow

83.27%-32.75M

31.53%-130.07M

757.05%51.04M

-387.95%-31.48M

360.99%46.05M

-11.51%-195.68M

-130.20%-189.96M

90.76%-7.77M

1,466.50%10.93M

-714.35%-17.64M

Financing cash flow

Cash flow from continuing financing activities

1,596.12%389.45M

-72.89%93.86M

-86.91%31.89M

-99.90%40K

0.48%38.97M

-4.78%22.96M

96.34%346.17M

1,076.28%243.65M

-74.47%39.62M

9,290.80%38.78M

Net common stock issuance

988.37%244.24M

-82.44%60.55M

--0

-0.46%38.11M

-6.90%22.44M

97.38%344.78M

2,577.96%243.08M

-76.26%39.32M

--38.28M

Net preferred stock issuance

----

--31.19M

----

--0

----

Proceeds from stock option exercised by employees

27,823.85%145.2M

52.80%2.13M

21.70%701K

-86.80%40K

72.17%866K

5,100.00%520K

-15.07%1.39M

-50.56%576K

791.18%303K

18.91%503K

Cash from discontinued financing activities

Financing cash flow

1,596.12%389.45M

-72.89%93.86M

-86.91%31.89M

-99.90%40K

0.48%38.97M

-4.78%22.96M

96.34%346.17M

1,076.28%243.65M

-74.47%39.62M

9,290.80%38.78M

Net cash flow

Beginning cash position

-45.58%185.38M

6.22%340.65M

-40.30%85.95M

22.99%154.18M

-14.88%118.96M

6.22%340.65M

-0.32%320.7M

-64.91%143.95M

-54.69%125.36M

-53.65%139.76M

Current changes in cash

229.15%286.32M

-878.37%-155.27M

-49.45%99.43M

-466.97%-68.23M

344.44%35.21M

-22.52%-221.69M

2,067.26%19.95M

319.61%196.7M

-86.08%18.59M

42.03%-14.41M

End cash Position

296.51%471.7M

-45.58%185.38M

-40.30%85.95M

22.99%154.18M

-14.88%118.96M

6.22%340.65M

-64.91%143.95M

-54.69%125.36M

Free cash flow

-40.38%-71.3M

11.36%-123.29M

139.06%15.64M

-18.40%-37.71M

-36.78%-50.43M

-67.44%-50.79M

-41.13%-139.09M

-43.40%-40.04M

-47.59%-31.85M

-27.82%-36.87M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-43.73%-70.38M	12.63%-119.06M	142.11%16.5M	-15.12%-36.79M	-40.12%-49.81M	-65.57%-48.97M	-43.72%-136.27M	-49.49%-39.19M	-53.78%-31.96M	-26.34%-35.55M
Net income from continuing operations	-31.42%-68.86M	-21.97%-212.22M	-19.76%-60.44M	-20.09%-52.36M	-2.92%-47.03M	-53.04%-52.39M	-47.44%-174M	-30.96%-50.47M	-48.93%-43.6M	-73.38%-45.69M
Depreciation and amortization	63.94%641K	51.48%2.1M	61.42%615K	52.97%566K	64.29%529K	24.52%391K	117.06%1.39M	83.17%381K	110.23%370K	119.05%322K
Other non cash items	20.35%828K	8.33%2.98M	21.00%824K	6.53%734K	6.09%732K	-0.15%688K	304.86%2.75M	--681K	--689K	--690K
Change In working capital	-128.51%-10.34M	764.99%61.13M	1,756.06%68.9M	109.76%7.41M	-515.44%-10.66M	-64.91%-4.53M	52.21%7.07M	-45.51%3.71M	-5.71%3.53M	141.06%2.57M
-Change in prepaid assets	-269.55%-2.53M	47.94%-3.44M	10.82%-3.01M	274.09%5.21M	-489.99%-7.13M	171.68%1.49M	-163.59%-6.62M	-207.32%-3.37M	-137.38%-2.99M	146.86%1.83M
-Change in payables and accrued expense	1.47%-3.96M	-76.11%4.91M	-43.20%5.53M	-42.79%4.87M	-170.30%-1.46M	-1,659.30%-4.02M	73.82%20.57M	96.13%9.73M	38.53%8.51M	265.28%2.07M
-Change in other current liabilities	-14.60%-887K	-88.88%-3.33M	-20.53%-916K	-8.92%-818K	-226.69%-820K	---774K	-652.99%-1.76M	---760K	---751K	---251K
-Change in other working capital	-142.90%-2.96M	1,330.21%62.99M	3,671.92%67.3M	-49.76%-1.84M	-15.04%-1.25M	-32.21%-1.22M	-15.21%-5.12M	-77.90%-1.88M	-8.66%-1.23M	0.64%-1.08M
Cash from discontinued investing activities
Operating cash flow	-43.73%-70.38M	12.63%-119.06M	142.11%16.5M	-15.12%-36.79M	-40.12%-49.81M	-65.57%-48.97M	-43.72%-136.27M	-49.49%-39.19M	-53.78%-31.96M	-26.34%-35.55M
Investing cash flow
Cash flow from continuing investing activities	83.27%-32.75M	31.53%-130.07M	757.05%51.04M	-387.95%-31.48M	360.99%46.05M	-11.51%-195.68M	-130.20%-189.96M	90.76%-7.77M	1,466.50%10.93M	-714.35%-17.64M
Net PPE purchase and sale	49.73%-915K	-49.77%-4.23M	-1.53%-863K	-962.62%-923K	52.95%-622K	-140.11%-1.82M	24.52%-2.82M	50.21%-850K	113.38%107K	-86.72%-1.32M
Net investment purchase and sale	83.58%-31.83M	32.75%-125.84M	850.26%51.9M	-382.27%-30.56M	385.94%46.67M	-10.96%-193.86M	-137.55%-187.13M	91.60%-6.92M	--10.83M	-555.92%-16.32M
Cash from discontinued investing activities
Investing cash flow	83.27%-32.75M	31.53%-130.07M	757.05%51.04M	-387.95%-31.48M	360.99%46.05M	-11.51%-195.68M	-130.20%-189.96M	90.76%-7.77M	1,466.50%10.93M	-714.35%-17.64M
Financing cash flow
Cash flow from continuing financing activities	1,596.12%389.45M	-72.89%93.86M	-86.91%31.89M	-99.90%40K	0.48%38.97M	-4.78%22.96M	96.34%346.17M	1,076.28%243.65M	-74.47%39.62M	9,290.80%38.78M
Net common stock issuance	988.37%244.24M	-82.44%60.55M	--0	--0	-0.46%38.11M	-6.90%22.44M	97.38%344.78M	2,577.96%243.08M	-76.26%39.32M	--38.28M
Net preferred stock issuance	----	--31.19M	----	----	----	----	--0	----	----	----
Proceeds from stock option exercised by employees	27,823.85%145.2M	52.80%2.13M	21.70%701K	-86.80%40K	72.17%866K	5,100.00%520K	-15.07%1.39M	-50.56%576K	791.18%303K	18.91%503K
Cash from discontinued financing activities
Financing cash flow	1,596.12%389.45M	-72.89%93.86M	-86.91%31.89M	-99.90%40K	0.48%38.97M	-4.78%22.96M	96.34%346.17M	1,076.28%243.65M	-74.47%39.62M	9,290.80%38.78M
Net cash flow
Beginning cash position	-45.58%185.38M	6.22%340.65M	-40.30%85.95M	22.99%154.18M	-14.88%118.96M	6.22%340.65M	-0.32%320.7M	-64.91%143.95M	-54.69%125.36M	-53.65%139.76M
Current changes in cash	229.15%286.32M	-878.37%-155.27M	-49.45%99.43M	-466.97%-68.23M	344.44%35.21M	-22.52%-221.69M	2,067.26%19.95M	319.61%196.7M	-86.08%18.59M	42.03%-14.41M
End cash Position	296.51%471.7M	-45.58%185.38M	-45.58%185.38M	-40.30%85.95M	22.99%154.18M	-14.88%118.96M	6.22%340.65M	6.22%340.65M	-64.91%143.95M	-54.69%125.36M
Free cash flow	-40.38%-71.3M	11.36%-123.29M	139.06%15.64M	-18.40%-37.71M	-36.78%-50.43M	-67.44%-50.79M	-41.13%-139.09M	-43.40%-40.04M	-47.59%-31.85M	-27.82%-36.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall